Society for Pediatric Dermatology

At the SPD 2022 47th Annual Meeting in Indianapolis, Candrice R. Heath, MD, FAAP, FAAD shares compelling best practices for treating patients of color with this condition.

Sleep disturbance is a significant factor in reduced quality of life for children and adolescents. A study at a poster session for the SPD 2022 47th Annual Meeting was presented on treating this population with dupilumab (Dupixent) to help with sleep quality showed positive results.

At the SPD 2022 47th Annual Meeting in Indianapolis, Indiana, a poster session on atopic dermatitis severity and outcomes in young children from 5 regions around the world.

Bernard A. Cohen, MD, shares what he thinks will be most exciting at this year's Society for Pediatric Dermatology Meeting in Indianapolis, Indiana.

An extraordinary display of posters at this year's Society for Pediatric Dermatology annual conference.

From pediatric dermatology quizzes to the latest news in telederm to practical pearls on atopic dermatitis, alopecia, and vitiligo, there’s a lot going on at the SPD 2022 47th Annual Meeting, this year in Indianapolis, Indiana.

Meena Julapalli, MD, notes the sessions she is most looking forward to at the 2022 SPD 47th Annual Meeting in Indianapolis, Indiana.

Lawrence Eichenfield, MD, is excited about the upcoming Society for Pediatric Dermatology Conference in Indianapolis July 7-10, where he will be presenting the AAP Section on Dermatology Alvin Jacobs Award to Sheila Fallon Friedlander, MD

Recognize whether the test being ordered is the right one for the condition suspected, as well as whether the patient’s insurance company will fund it, Jennifer Hand, M.D., told colleagues at the Society for Pediatric Dermatology Annual Meeting this weekend in Austin, Texas.

Rajani Katta, M.D., shared some of the new triggers for contact dermatitis at this weekend's Society for Pediatric Dermatology Annual Meeting in Austin, Texas. With a practice nearly exclusively dedicated to treating this condition, she's seen a rising number of cases related to essential oils and flavorings.

While topical therapies may suffice for mild-to-moderate atopic dermatitis, systemic agents may become necessary for more severe disease. Peter Lio, M.D., discusses his approach to treatment utilizing available therapies.

Molluscum contagiosum can often have a negative impact on the quality of life of affected children. Recent data show high lesion clearance compared with placebo.